Profound Medical Corp. PROF
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.54M | -7.05M | -8.18M | -7.98M | -15.70M |
| Total Depreciation and Amortization | 135.00K | 100.00K | 109.00K | 147.00K | 141.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 927.00K | 1.10M | 1.38M | 1.67M | 1.44M |
| Change in Net Operating Assets | -2.86M | -2.73M | 123.00K | -3.45M | 366.00K |
| Cash from Operations | -11.34M | -8.58M | -6.57M | -9.61M | -13.74M |
| Capital Expenditure | -- | -- | -176.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -66.00K | -- | -- |
| Cash from Investing | -- | -- | -242.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | 42.44M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.02M | -- | -- |
| Cash from Financing | -- | -- | 41.43M | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -686.00K | -845.00K | 277.00K | -755.00K | 2.51M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.02M | -9.43M | 34.90M | -10.37M | -11.24M |